UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

The Bruton Tyrosine Kinase (BTK) Inhibitor Acalabrutinib Demonstrates Potent On-Target Effects and Efficacy in Two Mouse Models of Chronic Lymphocytic Leukemia

Clinical cancer research, 2017-06, Vol.23 (11), p.2831-2841

2017

Link zum Volltext

Verfügbarkeit prüfen

Aberrant Immunological Synapses Driven by Leukemic Antigen-Presenting Cells

Methods in molecular biology (Clifton, N.J.), 2017, Vol.1584, p.533

2017

Link zum Volltext

Verfügbarkeit prüfen

Long‐term population‐based risks of breast cancer after childhood cancer

International journal of cancer, 2008-11, Vol.123 (9), p.2156-2163

2008

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia

Blood, 2015-07, Vol.126 (2), p.203-211

2015

Link zum Volltext

Verfügbarkeit prüfen

Autologous Stem Cell Transplantation for Chronic Lymphocytic Leukemia - Still a Valid Treatment Option, or is the Game Over?

Mediterranean journal of hematology and infectious diseases, 2012-01, Vol.4 (1), p.e2012071-e2012071

2012

Link zum Volltext

Verfügbarkeit prüfen

T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production

Blood, 2013-02, Vol.121 (9), p.1612-1621

2013

Link zum Volltext

Verfügbarkeit prüfen

Transplantation in chronic lymphocytic leukemia: does it still matter in the era of novel targeted therapies?

Hematology/oncology clinics of North America, 2014-12, Vol.28 (6), p.1055

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of the Follicular Lymphoma International Prognostic Index Score in Marginal Zone Lymphoma: An Analysis of Clinical Presentation and Outcome in 144 Patients

Cancer, 2013, Vol.119 (1), p.99-106

2013

Link zum Volltext

Verfügbarkeit prüfen

Diffusion‐weighted imaging for non‐invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology

British journal of haematology, 2011-06, Vol.153 (6), p.721-728

2011

Link zum Volltext

Verfügbarkeit prüfen

Catching up with solid tumor oncology: what is the evidence for a prognostic role of programmed cell death-ligand 1/programmed cell death-1 expression in B-cell lymphomas?

Haematologica (Roma), 2016-10, Vol.101 (10), p.1144-1158

2016

Link zum Volltext

Verfügbarkeit prüfen

Rituximab maintenance improves survival in male patients with diffuse large B‐cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trial

British journal of haematology, 2015-12, Vol.171 (5), p.710-719

2015

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma

Cancer, 2013-01, Vol.119 (1), p.99-106

2013

Link zum Volltext

Verfügbarkeit prüfen

Aberrant PD-L1 Expression in CLL As a Result of Adaptive Immune Resistance Mediated By Tumor-Secreted Circulating miRNA Binding to Toll-like Receptor 7

Blood, 2014-12, Vol.124 (21), p.716-716

2014

Link zum Volltext

Verfügbarkeit prüfen

Immune Checkpoint Blockade with Anti-PD-L1 Prevents Immune Dysfuntion and CLL Development in the TCL1 Adoptive Transfer Mouse Model

Blood, 2014-12, Vol.124 (21), p.717-717

2014

Link zum Volltext

Verfügbarkeit prüfen

Minimal Renal Toxicity after Rituximab DHAP with a Modified Cisplatin Application Scheme in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma

Blood, 2015-12, Vol.126 (23), p.1506-1506

2015

Link zum Volltext

Verfügbarkeit prüfen

New insights into hematopoietic stem cell transplantation for chronic lymphocytic leukemia: a 2015 perspective

Clinical advances in hematology & oncology, 2015-09, Vol.13 (9), p.586-594

2015

Link zum Volltext

Verfügbarkeit prüfen

Exploring the Functional Relevance of BTK Beyond Chronic Lymphocytic Leukemia (CLL) Cells: BTK Expression in Non-Malignant Immune Cells of the Microenvironment Mediates CLL Development and Progression In Vivo

Blood, 2016-12, Vol.128 (22), p.352-352

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeting dysfunctional myeloid cells delays disease development and improves immune function in a CLL mouse model (TUM6P.1009)

The Journal of immunology (1950), 2015-05, Vol.194 (1_Supplement), p.141-141.33

2015

Link zum Volltext

Verfügbarkeit prüfen

AUTOLOGOUS STEM CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA STILL A VALID TREATMENT OPTION, OR IS THE GAME OVER ?

Mediterranean journal of hematology and infectious diseases, 2012-01, Vol.4 (1), p.e2012071-e2012071

2012

Link zum Volltext

Verfügbarkeit prüfen

Targeting Dysfunctional Myeloid Cells Delays Disease Development and Improves Immune Function in a CLL Mouse Model

Blood, 2014-12, Vol.124 (21), p.3298-3298

2014

Link zum Volltext

Verfügbarkeit prüfen

The Flavonoid Wogonin Reduces CLL Cell Survival in Vitro and Leukemia Development in Eµ-TCL1 Mice By Targeting Aberrant TNF Receptor Signaling

Blood, 2014-12, Vol.124 (21), p.1966-1966

2014

Link zum Volltext

Verfügbarkeit prüfen

T-Cell Dysfunction In CLL Is Mediated Not Only By PD-1/PD-L1 But Also By PD-1/PD-L2 Interactions - Partial Functionality Is Maintained In PD-1 Defined CD8 Subsets and This Can Be Further Promoted By Ibrutinib Treatment

Blood, 2013-11, Vol.122 (21), p.4120-4120

2013

Link zum Volltext

Verfügbarkeit prüfen

BRAFV600E Accelerates Disease Progression and Increases Immune Suppression in a Mouse Model of B-Cell Leukemia

Blood, 2016-12, Vol.128 (22), p.1206-1206

2016

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic Transplantation for Chronic Lymphocytic Leukemia in the Age of Novel Treatment Strategies

Oncology (Williston Park, N.Y.), 2016-06, Vol.30 (6), p.526-540

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(46)
Buchkapitel
(2)

Sprache

Englisch
(48)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(17)
Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Hematology
(10)
Female
(9)
Adult
(8)
Middle Aged
(8)
Aged
(7)
Male
(7)
Chronic Lymphocytic Leukemia
(6)
Oncology
(6)
Prognosis
(6)
Survival
(6)
Animals
(5)
Biological And Medical Sciences
(5)
Leukemia, Lymphocytic, Chronic, B-Cell - Genetics
(5)
Leukemia, Lymphocytic, Chronic, B-Cell - Pathology
(5)
Leukemia, Lymphocytic, Chronic, B-Cell - Therapy
(5)
Medical Sciences
(5)
Mice
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Bruton Tyrosine Kinase (BTK) Inhibitor Acalabrutinib Demonstrates Potent On-Target Effects and Efficacy in Two Mouse Models of Chronic Lymphocytic Leukemia

Aberrant Immunological Synapses Driven by Leukemic Antigen-Presenting Cells

Long‐term population‐based risks of breast cancer after childhood cancer

PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia

Autologous Stem Cell Transplantation for Chronic Lymphocytic Leukemia - Still a Valid Treatment Option, or is the Game Over?

T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production

Transplantation in chronic lymphocytic leukemia: does it still matter in the era of novel targeted therapies?

RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics

Prognostic Value of the Follicular Lymphoma International Prognostic Index Score in Marginal Zone Lymphoma: An Analysis of Clinical Presentation and Outcome in 144 Patients

Diffusion‐weighted imaging for non‐invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology

Catching up with solid tumor oncology: what is the evidence for a prognostic role of programmed cell death-ligand 1/programmed cell death-1 expression in B-cell lymphomas?

Rituximab maintenance improves survival in male patients with diffuse large B‐cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trial

Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma

Aberrant PD-L1 Expression in CLL As a Result of Adaptive Immune Resistance Mediated By Tumor-Secreted Circulating miRNA Binding to Toll-like Receptor 7

Immune Checkpoint Blockade with Anti-PD-L1 Prevents Immune Dysfuntion and CLL Development in the TCL1 Adoptive Transfer Mouse Model

Minimal Renal Toxicity after Rituximab DHAP with a Modified Cisplatin Application Scheme in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma

New insights into hematopoietic stem cell transplantation for chronic lymphocytic leukemia: a 2015 perspective

Exploring the Functional Relevance of BTK Beyond Chronic Lymphocytic Leukemia (CLL) Cells: BTK Expression in Non-Malignant Immune Cells of the Microenvironment Mediates CLL Development and Progression In Vivo

Targeting dysfunctional myeloid cells delays disease development and improves immune function in a CLL mouse model (TUM6P.1009)

AUTOLOGOUS STEM CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA STILL A VALID TREATMENT OPTION, OR IS THE GAME OVER ?

Targeting Dysfunctional Myeloid Cells Delays Disease Development and Improves Immune Function in a CLL Mouse Model

The Flavonoid Wogonin Reduces CLL Cell Survival in Vitro and Leukemia Development in Eµ-TCL1 Mice By Targeting Aberrant TNF Receptor Signaling

T-Cell Dysfunction In CLL Is Mediated Not Only By PD-1/PD-L1 But Also By PD-1/PD-L2 Interactions - Partial Functionality Is Maintained In PD-1 Defined CD8 Subsets and This Can Be Further Promoted By Ibrutinib Treatment

BRAFV600E Accelerates Disease Progression and Increases Immune Suppression in a Mouse Model of B-Cell Leukemia

Allogeneic Transplantation for Chronic Lymphocytic Leukemia in the Age of Novel Treatment Strategies

Suchergebnisse filtern